FDA approvals in 2025 introduced novel therapies and devices across ophthalmic subspecialties, emphasizing sustained efficacy ...
An overview of the top 10 stories from Optometry Times in 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback